FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 19.713
EU - Europa 9.398
AS - Asia 8.658
SA - Sud America 1.130
Continente sconosciuto - Info sul continente non disponibili 549
AF - Africa 137
OC - Oceania 17
Totale 39.602
Nazione #
US - Stati Uniti d'America 19.302
SG - Singapore 3.673
IT - Italia 1.896
IE - Irlanda 1.839
RU - Federazione Russa 1.801
CN - Cina 1.756
BR - Brasile 916
HK - Hong Kong 899
TR - Turchia 876
SE - Svezia 812
VN - Vietnam 792
DE - Germania 763
GB - Regno Unito 623
UA - Ucraina 490
FR - Francia 384
FI - Finlandia 345
CA - Canada 221
BD - Bangladesh 160
IN - India 134
NL - Olanda 79
ES - Italia 77
MX - Messico 76
JP - Giappone 75
AR - Argentina 68
CZ - Repubblica Ceca 50
PL - Polonia 47
ZA - Sudafrica 47
BE - Belgio 45
IQ - Iraq 36
CO - Colombia 34
ID - Indonesia 33
EC - Ecuador 29
LT - Lituania 28
PK - Pakistan 25
MA - Marocco 23
VE - Venezuela 23
AT - Austria 19
HN - Honduras 19
RO - Romania 19
EU - Europa 18
JM - Giamaica 18
KR - Corea 18
UZ - Uzbekistan 18
CR - Costa Rica 17
KE - Kenya 17
MY - Malesia 17
CL - Cile 16
PE - Perù 16
AU - Australia 15
JO - Giordania 15
IL - Israele 14
PH - Filippine 14
PY - Paraguay 14
TH - Thailandia 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
SA - Arabia Saudita 11
TN - Tunisia 10
TW - Taiwan 10
UY - Uruguay 10
EE - Estonia 9
HU - Ungheria 8
LB - Libano 8
NP - Nepal 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
DZ - Algeria 7
EG - Egitto 7
GT - Guatemala 7
KZ - Kazakistan 7
SV - El Salvador 7
DK - Danimarca 6
PR - Porto Rico 6
AL - Albania 5
BB - Barbados 5
CH - Svizzera 5
GE - Georgia 5
KG - Kirghizistan 5
NI - Nicaragua 5
SN - Senegal 5
LU - Lussemburgo 4
OM - Oman 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
PT - Portogallo 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GM - Gambi 2
Totale 39.026
Città #
San Jose 2.213
Singapore 2.102
Chandler 1.945
Jacksonville 1.921
Dublin 1.835
Dallas 1.642
Ashburn 1.430
Council Bluffs 1.260
Santa Clara 890
Hong Kong 879
Boardman 692
The Dalles 491
New York 438
Izmir 425
Milan 422
Moscow 353
Nanjing 338
Princeton 309
Lawrence 306
San Mateo 304
Wilmington 298
Ho Chi Minh City 250
Los Angeles 237
Lauterbourg 212
Beijing 210
Hanoi 187
Rome 163
Ann Arbor 156
Munich 123
Woodbridge 116
São Paulo 114
Columbus 108
Nanchang 108
Hefei 97
Des Moines 91
Mountain View 80
Seattle 80
Naples 73
Shenyang 73
Orem 72
Tokyo 68
Helsinki 66
Miano 66
Verona 61
Atlanta 58
Brooklyn 58
Phoenix 58
Amsterdam 57
Lappeenranta 57
Tianjin 57
Montreal 56
Hebei 55
London 53
Frankfurt am Main 52
L'aquila 50
Falls Church 48
Brno 45
Brussels 43
Chicago 43
Denver 43
Kunming 42
San Francisco 42
Jiaxing 41
Las Vegas 41
Warsaw 41
Jinan 40
Stockholm 40
Toronto 40
Houston 39
Turin 39
Dearborn 38
Shanghai 37
Bari 35
Dong Ket 35
Boston 34
Buffalo 34
Norwalk 34
Bologna 32
Da Nang 32
Florence 32
Changsha 29
Chennai 29
Falkenstein 29
Ningbo 29
Brasília 28
Turku 28
Belo Horizonte 26
Johannesburg 26
Manchester 26
L’Aquila 24
Nuremberg 24
Mexico City 23
Zhengzhou 23
Guangzhou 22
Haiphong 22
Philadelphia 21
Rio de Janeiro 21
Pune 20
Ankara 19
Bremen 18
Totale 25.372
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 254
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 225
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 195
Rapid response of scalp psoriasis to ustekinumab 173
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 172
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 170
A variant in FTO shows association with melanoma risk not due to BMI 163
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 162
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 162
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 161
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 161
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 160
Staging and follow-up of cutaneous Melanoma patients 156
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 153
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 153
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 153
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 152
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 152
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 152
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 151
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 149
Understanding the molecular genetics of basal cell carcinoma 149
EDNRB gene variants and melanoma risk in two southern European populations. 148
Cutaneous manifestations in Italian kidney transplant recipients 147
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 144
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 144
Dermoscopic features of actinic keratosis 142
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 141
On the interplay of telomeres, nevi and the risk of melanoma 140
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 140
Early stage melanoma diagnosis and mental health-related: emotional influence of body self-perception 140
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 139
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 139
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 139
Telomeres and telomerase in cutaneous squamous cell carcinoma 138
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 137
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 137
Pigmented reticular structures in basal cell carcinoma and collision tumours 136
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 135
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 134
The spectrum of dermatoscopic patterns in blue nevi 134
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 134
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 134
Management of Cutaneous Squamous Cell Carcinoma of the Scalp in Kidney Transplant Recipients 133
Parapsoriasi 133
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 132
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 132
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 132
Treatments of advanced basal cell carcinoma: a review of the literature 131
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 131
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 130
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 130
Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis 130
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 130
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 130
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 130
T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review 129
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts 129
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 129
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 129
Interferon-beta injection site reactions in patients with multiple sclerosis 129
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin 128
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations 128
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 128
Early Diagnosis of Melanoma and Breast Cancer in Women: Influence of Body Image Perception 127
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 127
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 127
Mucosal involvement in a patient with lymphomatoid papulosis 127
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 127
Dermoscopic evolution of a congenital combined nevus in childhood 127
Molecular alterations in basal cell carcinoma subtypes 127
Mycosis fungoides. Clinical and molecular biology observations 126
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 126
"Your Skin Tells You" Campaign for keratinocyte cancers: when individuals' selection makes the difference 125
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History 125
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 125
Pilotropic mycosis fungoides presenting as an acneiform eruption 125
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 125
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 125
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 125
Basal cell carcinoma and inflammation: role of the Gadd45b gene 125
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 125
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 124
Comprehensive Evaluation of Allele Frequency Differences of MC1R Variants Across Populations 124
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 124
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 124
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 124
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 123
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 123
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 123
Italian expert consensus paper on the management of patients with actinic keratoses 123
CONSTITUTIONAL AND ENVIROMENTAL RISK FACTORS FOR CUTANEOUS MELANOMA IN ITALIAN POPULATION. A CASE-CONTROL STUDY 122
Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis 121
Occurrence of multiple melanomas in a patient with punctate palmoplantar keratoderma type-1A associated to alpha and gamma adaptin binding protein 121
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 121
Photodynamic therapy for the treatment of micro invasive squamous cell carcinoma of the lower lip: a case report 121
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 121
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 120
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 120
Family history of psoriasis and age at disease onset in Italian patients with psoriasis 120
Totale 13.798
Categoria #
all - tutte 176.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.162 0 0 0 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20256.230 165 108 590 222 734 573 902 480 1.440 200 450 366
2025/202612.781 540 1.061 1.118 1.346 1.190 783 2.381 613 1.130 1.422 956 241
2026/20274.835 446 542 1.138 2.709 0 0 0 0 0 0 0 0
Totale 39.602